Transgene Biotek
4.43
-0.03(-0.67%)
Market Cap₹33.80 Cr
PE Ratio-
Company Performance:
1D-0.67%
1M-9.22%
6M+9.11%
1Y-51.80%
5Y-19.01%
View Company Insightsright
Latest news about Transgene Biotek
Transgene Biotek Reports Q1 Loss, Appoints New Auditors Amid Ongoing Regulatory Challenges Aug 07, 2025
Transgene Biotek Limited reported a net loss of Rs 43.37 lakhs in Q1, compared to a profit of Rs 19.94 lakhs in the same period last year. Revenue from operations slightly increased to Rs 4.95 lakhs. The company appointed new Internal and Secretarial Auditors. Regulatory challenges persist, with ongoing proceedings at the Securities Appellate Tribunal and Appellate Tribunal in New Delhi. The company cleared the principal sum owed to BIRAC but faces operational difficulties due to regulatory issues.